Hydromorphone HCL PF recall — Class III (D-0023-2026) · pharmaranks
Class IIIOngoing
Hydromorphone HCL PF recall
FDA recall D-0023-2026 · initiated Oct 9, 2025
Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
Why it was recalled
Labeling: Incorrect or Missing Lot and/or Exp Date
Details
Product
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Recalling company
STAQ Pharma, Inc.
Classification
Class III
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the U.S.
Initiated
Oct 9, 2025
FDA report date
Oct 22, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.